Michael Phelps
Michael Phelps
Founder & Peptide Research Specialist, PrymaLab
Michael Phelps is the founder of PrymaLab and the author of its research library — a growing set of research-use-only reference articles on how peptides behave at the level of cells, receptors, and signaling pathways. His focus is simple: pair genuinely useful, well-sourced scientific writing with transparent quality standards so researchers can trust both the information and the material.
About Michael
Michael founded PrymaLab to bring transparency and an education-first approach to the research-peptide space. Rather than treat peptides as commodities, he built PrymaLab around the idea that a research compound is only as good as its documentation — its identity, its purity, and the paper trail that proves both. That conviction runs through everything he publishes.
As the primary author of the PrymaLab Research Library, Michael writes long-form reference articles that translate the primary literature — PubMed, PMC, and peer-reviewed journals — into clear, cited explanations of peptide mechanisms. Each article is written for researchers first: answer-first, heavily sourced, and framed strictly for research use only, with no human-dosing or therapeutic claims.
His work spans the peptides PrymaLab studies and supplies — from TREK-1 and growth-hormone signaling to copper-peptide follicle biology, short-peptide bioregulators, and oxytocin's neuronal circuits — always anchored to the underlying cell and receptor science.
Areas of Expertise
- Research peptide chemistry
- Solid-phase peptide synthesis (SPPS)
- HPLC purity analysis
- Mass-spectrometry identity confirmation
- Endotoxin & third-party testing
- Cellular signaling & receptor pharmacology
- Research-use-only (RUO) standards
- Science communication & literature review
Editorial & Quality Standards
Primary-source sourcing. Every key claim in the research library is linked to authoritative literature (PubMed, PMC, and peer-reviewed journals) so readers can verify it directly.
Research-use-only framing. All articles describe in-vitro and animal-model findings in hedged, mechanistic terms. Nothing is presented as medical advice or human-dosing guidance.
Verified material. PrymaLab research peptides are characterized by reversed-phase HPLC for purity and mass spectrometry for identity, with independent third-party testing, so experimental results reflect the peptide — not a contaminant.
Kept current. Reference articles carry a visible "last updated" date and are revised as new literature appears.
Connect
LinkedIn ORCID Instagram Facebook
PrymaLab Research Library by Michael Phelps
- PE-22-28 and Nerve Cells: TREK-1 Blockade, Serotonin, and Neuroplasticity
- Pal-AHK and Follicular Cells: Copper-Peptide Signaling, Growth, and Apoptosis
- Tesamorelin: Anabolic Growth and Catabolic Fat Metabolism
- PNC-27 and Tumor Cell Lines: Membrane HDM-2 and Necrosis
- T-31 (Cartalax) and Cellular Aging: Senescence, Renewal, and Stress
- Kisspeptin 45-54: Hypothalamic Signaling, Reproduction, and Neuroprotection
- Thymogen (Glu-Trp) and Immune Cell Regulation
- CJC-1295 & Hexarelin: GHRH Analog + Growth Hormone Secretagogue
- Oxytocin and Neuronal Circuits: OXTR Signaling, Reward, and Fear
PrymaLab research articles are educational references about research-use-only compounds. They are not medical advice, and the peptides discussed are not approved for human or veterinary use. Always verify the legal status of any research compound in your jurisdiction before purchase or use.
